Viewing stories from September, 2011
Ms Zita Peach appointed Non-Executive Director
Starpharma today announced the appointment of Ms Zita Peach as a Non-Executive Director.
Zita has more than 20 years of commercial experience in the pharmaceutical industry, particularly in marketing and business development, working for major industry players such as CSL Limited and Merck Sharp & Dohme (MSD), the Australian subsidiary of Merck Inc.
Starpharma elevated to S&P/ASX300 index
Starpharma has received notification that it will be elevated to the S&P/ASX 300 Index, effective from 19th September.